Sponsor Pipeline

Kangbuk Samsung Hospital Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
8
Active Trials
4
Recruiting
4
Disease Areas
Active Trials by Phase
Phase 1/2
1
Not specified
7
Active Trials
NCT IDTitleConditionStatus
Phase 1/2
NCT05640830 Trastuzumab, Bevacizumab with Paclitaxel for HER2-positive Gastric Cancer in a… HER2-positive Advanced Gastric Cancer Recruiting
Not specified
NCT02803970 KOrean Borderline Ovarian Tumor (KOBOT) Registry Ovarian Neoplasms Recruiting
NCT06542627 Continuous Glucose Monitoring for Glucose and Weight Management in Prediabetes and… PreDiabetes Recruiting
NCT07336329 Continuous Glucose Monitoring in Non-Insulin Treated Type 2 Diabetes: Continuous vs… Diabetes Mellitus, Type 2 Recruiting
NCT06130137 Gut Microbiome in People Living With HIV and HBV Human Immunodeficiency Virus Not Yet Recruiting
NCT06773585 Investigations of Factors Associated With Treatment Response and Prognosis in Anxiety… Panic Disorder Not Yet Recruiting
NCT07298850 A Study on the Effect of CGM Alone on Glycemic Metrics in Type 2 Diabetes Patients Not… Continuous Glucose Monitoring Active, Not Recruiting
NCT07396961 Consistency of ASIS Line vs. Tuffier's Line for Lumbar Level Identification Spinal Anesthesia Evaluation Not Yet Recruiting
Disease Areas
Get alerts when Kangbuk Samsung Hospital's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free